Wellstar International, Inc. Announces Additional Appointment to Medical Advisory Board
29 Septembre 2008 - 5:42PM
Marketwired
Wellstar International, Inc. (OTCBB: WLSI), a developer of thermal
imaging, diagnostic software and equipment, announced today that it
has made another key appointment to its medical advisory board. Ms.
Edna Edwards Atwater, RN, BSN, widely respected as a premier wound
care specialist, and current administrator at the Wound Management
Institute of Duke University Medical Center, has already been
serving as consultant to Wellstar and will now join Dr. Shen, Dr.
Makowka and Courtney Lyder, ND to advise the rapidly emerging
company on the medical and health care administration aspects of
the Company's business activities.
EDNA EDWARDS ATWATER, RN, BSN
Edna Edwards Atwater has been a registered nurse in the state of
North Carolina since 1975. Among her professional appointments, she
has served as President of the Dermatology Nurses' Association,
Chairperson of the Surgical Core Curriculum, Dermatology Nurses'
Association, on the Health Policy Committee, National Federation of
Specialty Nursing Organization, and Dermatology Nurses' Association
Representative to the National Pressure Ulcer Advisory Panel.
Atwater has served as an administrator / director for the Wound
Management Institute of Duke University Medical Center, in addition
to several other key roles for Duke, since 1998. Wellstar is very
pleased that Edna Edwards Atwater has agreed to join the Company's
advisory board, and anticipates that she will play a very big role
in the Company's efforts to roll-out its thermal imaging systems
nationwide.
Current shareholders and interested investors seeking additional
biographical / background information on Edna Edwards Atwater, or
any of the four newly appointed advisors to Wellstar, should visit
the Company's corporate Website at www.wellstar.us. Curriculum
vitae for all four can be downloaded in PDF format. In addition,
interested investors seeking further information are encouraged to
call the Company's investor relations' representatives toll-free at
(800) 953-3350.
ABOUT WELLSTAR INTERNATIONAL, INC:
Wellstar International, Inc., through its wholly owned operating
subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the health care industry.
TMI has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website, by
visiting: www.wellstar.us.
FORWARD-LOOKING STATEMENTS:
This press release contains statements, which may constitute
'forward- looking statements' within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual
results to differ materially from those in forward-statements
include fluctuation of operating results, the ability to compete
successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
CONTACT: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free,
U.S. & Canada (858) 436-3350 Local or International
Wellstar (CE) (USOTC:WLSI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Wellstar (CE) (USOTC:WLSI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024